Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777331
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-12-13
First Post:
2021-02-26
Brief Title:
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinsons Disease
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-05
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-27
Completion Date Type:
ESTIMATED
First Submit Date:
2021-02-26
First Submit QC Date:
February 26 2021
Study First Post Date:
2021-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-21
Last Update Post Date:
2023-12-13
Last Update Post Date Type:
ACTUAL